Run Chang

Title: The Innovative Contributions of Run Chang

Introduction

Run Chang is an accomplished inventor based in Brighton, MA (US). He has made significant strides in the field of antimicrobial treatments, holding a total of 2 patents. His work focuses on developing novel peptide-based solutions to combat drug-resistant bacteria.

Latest Patents

Run Chang's latest patents include the development of heparin-binding cationic peptide self-assembling peptide amphiphiles. These innovative peptides comprise an amphiphilic backbone and a cationic heparin-binding motif. They are designed for use in methods of antimicrobial treatment, showcasing their potential to address the growing issue of drug-resistant bacteria.

Career Highlights

Run Chang is affiliated with Northeastern University, where he contributes to research and development in the field of antimicrobial therapies. His work is pivotal in advancing the understanding and application of peptide-based treatments.

Collaborations

Run Chang collaborates with notable colleagues, including Keerthana Subramanian and Mian Wang. Their combined expertise enhances the research efforts at Northeastern University, fostering innovation in the field.

Conclusion

Run Chang's contributions to antimicrobial treatment through his innovative patents highlight the importance of research in combating drug-resistant bacteria. His work at Northeastern University continues to pave the way for future advancements in this critical area of healthcare.